188 related articles for article (PubMed ID: 27618277)
1. Relative Bradycardia in Patients With Septic Shock Requiring Vasopressor Therapy.
Beesley SJ; Wilson EL; Lanspa MJ; Grissom CK; Shahul S; Talmor D; Brown SM
Crit Care Med; 2017 Feb; 45(2):225-233. PubMed ID: 27618277
[TBL] [Abstract][Full Text] [Related]
2. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
Fawzy A; Evans SR; Walkey AJ
Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
[TBL] [Abstract][Full Text] [Related]
3. Low-dose corticosteroid treatment in septic shock: a propensity-matching study.
Funk D; Doucette S; Pisipati A; Dodek P; Marshall JC; Kumar A;
Crit Care Med; 2014 Nov; 42(11):2333-41. PubMed ID: 25072758
[TBL] [Abstract][Full Text] [Related]
4. Effect of norepinephrine on the outcome of septic shock.
Martin C; Viviand X; Leone M; Thirion X
Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
[TBL] [Abstract][Full Text] [Related]
5. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
6. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Bauer SR; Lam SW; Cha SS; Oyen LJ
J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Vasopressin Use for Adults with Septic Shock.
Vail EA; Gershengorn HB; Hua M; Walkey AJ; Wunsch H
Ann Am Thorac Soc; 2016 Oct; 13(10):1760-1767. PubMed ID: 27404213
[TBL] [Abstract][Full Text] [Related]
8. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
Zechmeister C; Hurren J; McNorton K
Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
[TBL] [Abstract][Full Text] [Related]
9. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
[TBL] [Abstract][Full Text] [Related]
10. Multi-complexity measures of heart rate variability and the effect of vasopressor titration: a prospective cohort study of patients with septic shock.
Brown SM; Sorensen J; Lanspa MJ; Rondina MT; Grissom CK; Shahul S; Mathews VJ
BMC Infect Dis; 2016 Oct; 16(1):551. PubMed ID: 27724850
[TBL] [Abstract][Full Text] [Related]
11. Before-after study of a standardized hospital order set for the management of septic shock.
Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH
Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
[TBL] [Abstract][Full Text] [Related]
12. Timing of vasopressor initiation and mortality in septic shock: a cohort study.
Beck V; Chateau D; Bryson GL; Pisipati A; Zanotti S; Parrillo JE; Kumar A;
Crit Care; 2014 May; 18(3):R97. PubMed ID: 24887489
[TBL] [Abstract][Full Text] [Related]
13. Dopamine therapy in septic shock: detrimental effect on survival?
Boulain T; Runge I; Bercault N; Benzekri-Lefevre D; Wolf M; Fleury C
J Crit Care; 2009 Dec; 24(4):575-82. PubMed ID: 19327324
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Organ Dysfunction Is Associated With Long-Term (10-Yr) Mortality of Septic Shock.
Linder A; Lee T; Fisher J; Singer J; Boyd J; Walley KR; Russell JA
Crit Care Med; 2016 Aug; 44(8):e728-36. PubMed ID: 27428136
[TBL] [Abstract][Full Text] [Related]
15. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: A multicentre evaluation.
Domizi R; Calcinaro S; Harris S; Beilstein C; Boerma C; Chiche JD; D'Egidio A; Damiani E; Donati A; Koetsier PM; Madden MP; McAuley DF; Morelli A; Pelaia P; Royer P; Shankar-Hari M; Wickboldt N; Zolfaghari P; Singer M
J Crit Care; 2020 Jun; 57():185-190. PubMed ID: 32171905
[TBL] [Abstract][Full Text] [Related]
16. Fever control using external cooling in septic shock: a randomized controlled trial.
Schortgen F; Clabault K; Katsahian S; Devaquet J; Mercat A; Deye N; Dellamonica J; Bouadma L; Cook F; Beji O; Brun-Buisson C; Lemaire F; Brochard L
Am J Respir Crit Care Med; 2012 May; 185(10):1088-95. PubMed ID: 22366046
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial.
Póvoa P; Salluh JI; Martinez ML; Guillamat-Prats R; Gallup D; Al-Khalidi HR; Thompson BT; Ranieri VM; Artigas A
Crit Care; 2015 Apr; 19(1):193. PubMed ID: 25928214
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS
Crit Care Med; 2010 Apr; 38(4):1101-7. PubMed ID: 20154607
[TBL] [Abstract][Full Text] [Related]
19. Early intravenous unfractionated heparin and mortality in septic shock.
Zarychanski R; Doucette S; Fergusson D; Roberts D; Houston DS; Sharma S; Gulati H; Kumar A
Crit Care Med; 2008 Nov; 36(11):2973-9. PubMed ID: 18824906
[TBL] [Abstract][Full Text] [Related]
20. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
